Deborah Kelly

943 total citations
39 papers, 549 citations indexed

About

Deborah Kelly is a scholar working on Infectious Diseases, Epidemiology and Geriatrics and Gerontology. According to data from OpenAlex, Deborah Kelly has authored 39 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 13 papers in Epidemiology and 8 papers in Geriatrics and Gerontology. Recurrent topics in Deborah Kelly's work include HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (10 papers) and Pharmaceutical Practices and Patient Outcomes (8 papers). Deborah Kelly is often cited by papers focused on HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (10 papers) and Pharmaceutical Practices and Patient Outcomes (8 papers). Deborah Kelly collaborates with scholars based in Canada, United States and Australia. Deborah Kelly's co-authors include Stephanie Young, Leslie Phillips, John Hawboldt, Lisa Bishop, L Béïque, Christine Hughes, Anthony Harnden, Martin Ward Platt, Gale Pearson and Linda Robinson and has published in prestigious journals such as AIDS, BMC Public Health and Archives of Disease in Childhood.

In The Last Decade

Deborah Kelly

32 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Kelly Canada 11 173 140 123 109 75 39 549
Juliana de Oliveira Costa Brazil 15 73 0.4× 115 0.8× 83 0.7× 86 0.8× 61 0.8× 53 620
Heather Kirkham United States 11 82 0.5× 261 1.9× 151 1.2× 204 1.9× 32 0.4× 24 532
Meiqi He United States 12 75 0.4× 212 1.5× 77 0.6× 204 1.9× 33 0.4× 28 630
Anthony K. Wutoh United States 14 43 0.2× 109 0.8× 142 1.2× 101 0.9× 88 1.2× 42 558
Sonali Kulkarni United States 12 57 0.3× 140 1.0× 134 1.1× 152 1.4× 23 0.3× 19 548
Patience Moyo United States 17 123 0.7× 52 0.4× 159 1.3× 240 2.2× 77 1.0× 62 836
Destaw Fetene Teshome Ethiopia 13 29 0.2× 121 0.9× 111 0.9× 111 1.0× 186 2.5× 42 587
Tsi Njim Cameroon 17 24 0.1× 78 0.6× 242 2.0× 125 1.1× 176 2.3× 56 796
Yosef Dlugacz United States 12 48 0.3× 179 1.3× 84 0.7× 137 1.3× 58 0.8× 33 692
Eric Sarpong United States 14 275 1.6× 42 0.3× 90 0.7× 180 1.7× 71 0.9× 52 750

Countries citing papers authored by Deborah Kelly

Since Specialization
Citations

This map shows the geographic impact of Deborah Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Kelly more than expected).

Fields of papers citing papers by Deborah Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Kelly. The network helps show where Deborah Kelly may publish in the future.

Co-authorship network of co-authors of Deborah Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Kelly. A scholar is included among the top collaborators of Deborah Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Kelly. Deborah Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Black, Emily, et al.. (2025). Pharmacists’ acceptability of provision of sexually transmitted infection services: a scoping review. International Journal of Pharmacy Practice. 33(4). 369–377.
2.
Murphy, Andrea, Jennifer E. Isenor, Deborah Kelly, et al.. (2025). Implementation and acceptance of pharmacists’ prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 158(5). 302–311.
3.
Kelly, Deborah, et al.. (2024). How to change workflow to enhance implementation of professional services in community pharmacies: A deprescribing case study. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 157(4). 164–170.
4.
Turner, Justin P., et al.. (2024). Strategies to guide the successful implementation of deprescribing in community practice: Lessons learned from the front line. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 157(3). 133–142. 4 indexed citations
5.
Farrell, Alison, et al.. (2023). Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs – a scoping review of the qualitative evidence. BMC Public Health. 23(1). 1038–1038. 9 indexed citations
6.
Murphy, Andrea, Jennifer E. Isenor, Alesha Smith, et al.. (2023). Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 156(4). 194–203. 3 indexed citations
7.
Murphy, Andrea, Jennifer E. Isenor, Alesha Smith, et al.. (2023). Community pharmacists’ acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 156(3). 137–149. 4 indexed citations
8.
Kesler, Maya, et al.. (2022). Pharmacist-delivered HIV point-of-care testing in Ontario: Lessons learned from the GetaTest pilot. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 155(6). 309–314. 2 indexed citations
9.
Loutfy, Mona, Curtis Cooper, Abigail Kroch, et al.. (2022). Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study. The Canadian Journal of Hospital Pharmacy. 75(4). 309–316. 1 indexed citations
10.
Kelly, Deborah, et al.. (2022). Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study. International Journal of Clinical Pharmacy. 44(6). 1370–1379. 8 indexed citations
11.
Blache, Dominique, Jill N. Fernandes, Helen E. Jenkins, et al.. (2021). Impact of the COVID-19 Pandemic on the Welfare of Animals in Australia. Frontiers in Veterinary Science. 7. 621843–621843. 20 indexed citations
12.
Kelly, Deborah, et al.. (2021). Establishing the Medication Therapy Services Clinic: Goals, challenges and future directions. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 154(3). 144–148. 2 indexed citations
13.
Sereda, Paul, Erin Ding, Alex Wong, et al.. (2021). Clinical and demographic predictors of antiretroviral efficacy in HIV–HBV co-infected patients. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 6(2). 137–148. 2 indexed citations
14.
Sereda, Paul, Erin Ding, Alex Wong, et al.. (2019). Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada. BMC Infectious Diseases. 19(1). 982–982. 9 indexed citations
15.
Bader, Mazen S., Annie Brooks, Deborah Kelly, & Jocelyn A. Srigley. (2017). Postexposure management of infectious diseases. Cleveland Clinic Journal of Medicine. 84(1). 65–80. 1 indexed citations
16.
Kelly, Deborah, et al.. (2014). Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 147(4). 239–247. 75 indexed citations
17.
18.
Hughes, Christine, Michelle Foisy, Norman Dewhurst, et al.. (2008). Abacavir Hypersensitivity Reaction: an Update. Annals of Pharmacotherapy. 42(3). 387–396. 43 indexed citations
19.
Kelly, Deborah, et al.. (2002). Extrapyramidal Symptoms with Ritonavir/Indinavir Plus Risperidone. Annals of Pharmacotherapy. 36(5). 827–830. 37 indexed citations
20.
Walmsley, Sharon, Deborah Kelly, Alice Tseng, Atul Humar, & P. Richard Harrigan. (2001). Non-nucleoside reverse transcriptase inhibitor failure impairs HIV-RNA responses to efavirenz-containing salvage antiretroviral therapy. AIDS. 15(12). 1581–1584. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliana de Oliveira Costa Breakdown of academic impact, for papers by Heather Kirkham Breakdown of academic impact, for papers by Meiqi He Breakdown of academic impact, for papers by Anthony K. Wutoh Breakdown of academic impact, for papers by Sonali Kulkarni Breakdown of academic impact, for papers by Patience Moyo Breakdown of academic impact, for papers by Destaw Fetene Teshome Breakdown of academic impact, for papers by Tsi Njim Breakdown of academic impact, for papers by Yosef Dlugacz Breakdown of academic impact, for papers by Eric Sarpong
Rankless by CCL
2026